Colonial Trust Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.3K Hold
150
0.01% 287
2025
Q4
$101K Hold
150
0.01% 268
2025
Q3
$95.8K Hold
150
0.01% 267
2025
Q2
$80.5K Hold
150
0.01% 285
2025
Q1
$63K Hold
150
0.01% 308
2024
Q4
$62K Hold
150
0.01% 287
2024
Q3
$75.8K Hold
150
0.01% 289
2024
Q2
$73.1K Hold
150
0.01% 283
2024
Q1
$81K Hold
150
0.01% 269
2023
Q4
$83.3K Hold
150
0.01% 264
2023
Q3
$65.6K Hold
150
0.01% 300
2023
Q2
$75.3K Hold
150
0.01% 286
2023
Q1
$75K Hold
150
0.01% 286
2022
Q4
$61.2K Buy
+150
New +$58.2K 0.01% 307

Other funds holding IDXX

Colonial Trust Advisors's IDXX Position: Q1 2026 in Review

Colonial Trust Advisors held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 150 shares worth $84.3K. The position accounts for 0.01% of the portfolio, ranked #287.

Colonial Trust Advisors first reported a position in IDXX in Q4 2022 and has held it in 14 quarters since. The position peaked at $101K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Colonial Trust Advisors held 150 shares of Idexx Laboratories worth $84.3K as of Q1 2026.
  • Colonial Trust Advisors left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #287 holding.
  • Colonial Trust Advisors first reported a position in Idexx Laboratories in Q4 2022 and has held it in 14 quarters since.
  • Colonial Trust Advisors's Idexx Laboratories position peaked at $101K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.